We demonstrate that KA specifically prevents NLRP3 inflammasome activation by mitigating calcium mobilization and mitochondrial damage and mitochondrial ROS production via GPR35, which improves inflammatory diseases and metabolic disorders. This evidence concerns the gene NLRP3 and metabolic disease.